Japan is a leading destination for CGT&RM development and manufacturing, thanks to its advanced technological capabilities, attractive patient population, and enabling regulatory landscape. However, developing and manufacturing CGT&RMs can be expensive and involve considerable hurdles, especially in an unfamiliar territory, where you may lack knowledge of regional regulations and processes.
Our free guide will help you explore your options and maximize your chances of success in developing and manufacturing CGT&RMs in Japan. It covers:
- The different options available to foreign pharmaceutical and biotech companies for CGT&RM manufacture in Japan
- The benefits of working with a Japan-based CDMO
- Key capabilities to look for in a success-enabling Japan-based CDMO partner
Fill out this brief form to download your free guide today and discover the key to success in developing and manufacturing CGT&RMs in Japan.